1-(4-carboxyphenyl)-3,3-dimethyltriazene has been researched along with Lymphoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cox, PJ; Goddard, PM; Hart, LI; Merai, K; Newell, DR; Wilman, DE | 1 |
| Goddard, PM; Wilman, DE | 1 |
| Giraldi, T; Lassiani, L; Nisi, C; Sava, G | 1 |
| Boccù, E; Lassiani, L; Nisi, C; Perissin, L; Sava, G; Varnavas, A | 1 |
| Lassiani, L; Nisi, C; Pacor, S; Perissin, L; Sava, G; Varnavas, A; Zorzet, S | 1 |
5 other study(ies) available for 1-(4-carboxyphenyl)-3,3-dimethyltriazene and Lymphoma
| Article | Year |
|---|---|
Tumor inhibitory triazenes. 3. Dealkylation within an homologous series and its relation to antitumor activity.
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Female; Lymphoma; Mathematics; Mice; Mice, Inbred CBA; Microsomes, Liver; Structure-Activity Relationship; Triazenes | 1984 |
Tumor inhibitory triazenes. 2. Variation of antitumor activity within an homologous series.
Topics: Animals; Antineoplastic Agents; Female; Lymphoma; Mice; Mice, Inbred CBA; Neoplasms, Experimental; Solubility; Structure-Activity Relationship; Triazenes | 1980 |
Metabolism and mechanism of the antileukemic action of isomeric aryldimethyltriazenes.
Topics: Animals; Antineoplastic Agents; Biotransformation; Brain Neoplasms; Dose-Response Relationship, Drug; Half-Life; Isomerism; Kinetics; Leukemia, Experimental; Lymphoma; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Structure-Activity Relationship; Triazenes | 1982 |
Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
Topics: Animals; Antineoplastic Agents; Cinnamates; Kinetics; Lung Neoplasms; Lymphoma; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Phenylbutyrates; Triazenes | 1991 |
Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.
Topics: Animals; Antineoplastic Agents; Carcinoma; Drug Screening Assays, Antitumor; Lung Neoplasms; Lymphoma; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Neoplasm Transplantation; Survival Rate; Triazenes | 1991 |